Abstract. Subclinical mastitis (SCM) is the most common form of mastitis and the greatest cause for concern in dairy cows. The overuse of antibiotics for the treatment of mastitis leads to the development of resistance, resulting in the use of symbiotics. The study was carried out between February and May 2017 at a pilot dairy cattle farm in the Tipaza region (north-central Algeria) aiming to investigate the effect of a symbiotic on SCM. California Mastitis test (CMT) was used to diagnose SCM in a total of 240 dairy cows. A number of 58/240 (24.16%) cows were found to have SCM. These mastitis cows were then divided into two lots; an experimental lot of 37 cows and a control lot of 21 cows. A symbiotic was administered to the experimental lot once a month for three months. Cell count, microbiological analysis and analysis of certain physicochemical parameters of the milk were applied before and after each administration of the symbiotic. The results revealed that the average somatic cells count (SCC) in cows from the control lot was higher than that of cows from the experimental lot throughout the study period (p<0.0001). Staphylococci were isolated from 51/58 (87.93%) of the mastitis cows, of which 21 (36.20%) were infected with Staphylococcus aureus and 30 (51.72%) with coagulase-negative Staphylococcus. Enterobacteriaceae were isolated from 36/58 (62.07%) of the mastitis cows, of which 21 (36.20%) were due to Escherichia coli strain and 15 (25.86%) to other strains of Enterobacteriaceae. After administration of the symbiotic, the prevalence of S. aureus and E. coli decreased significantly in the experimental lot compared to the control lot (p<0.001). The physicochemical characteristics of the milk were not altered by the administration of the symbiotic. All these results show that the symbiotic constitutes an adequate solution to replace antibiotics in the treatment of SCM.
Mastitis in cows is a major problem in dairy farms leading to a decrease in the quantity and quality of milk. The aim of the present study was to examine the association between the presence of Escherichia coli (E. coli) in milk and the subclinical mastitis, and to characterize the antibiotic resistance profiles of the isolated E. coli. In the current study, a total of 360 cow raw milk samples from three dairy farms of the region of Algiers were analyzed. The analysis period lasted from Spring 2017 to Winter 2019. The California Mastitis Test (CMT) was applied to detect subclinical mastitis. The E. coli strains were isolated from milk using conventional bacteriological methods. The antibiotic resistance profile of the isolated E. coli strains to 12 different antibiotics was tested using the disk diffusion method. On β-lactamase-producing strains, a double diffusion test was applied to identify the Extended-spectrum β-lactamase (ESBL) phenotype. Finally, the ctXx-M genes were amplified by PCR. Two-thirds (66.4%) of the milk samples were positive for the CMT test. A total of 97 E. coli strains were isolated from the milk samples, their resistance to antibiotics was tested, and 3.1% of the strains were resistant to trimethoprim-sulfamethoxazole, 6.2% to chloramphenicol, 12.3% to gentamicin, 13.4% to colistin, 23.3% to amoxicillin/clavulanate, 31.9% to kanamycin, 39.2% to enrofloxacin, 51.5% to cefotaxime, 52% to tetracycline, 57.7% to ampicillin, 74.3% to nalidixic acid, and 75.3% to amoxicillin. Furthermore, most of the E. coli strains (92.8%) were resistant to more than one antibiotic with a Multiple Antibiotic Resistance index ranging from 0 to 0.8. The 50 strains resistant to cefotaxime were analyzed for an ESBL phenotype. 39 of them (78%) were positive to the double-disk synergy test. Among the 39 ESBL positive strains, 27 (69.2%) were confirmed for the presence of a CTX-M gene by PCR. The present study showed that multiple drug-resistant E. coli, including ESBL-carriers, were frequently isolated from the milk of dairy cows in Algeria. The results underlined that the use of antibiotics on farms must be reasoned to avoid the spread of resistant strains in animals and human populations.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.